Hello, everyone, and how are you today? We are doing just fine, despite a menacing tuft of gray clouds hovering over the Pharmalot campus. After all, why not look on the sunny side? Meanwhile, please join us for a delicious cup or three of stimulation — our flavor today is cinnamon vanilla nut, for those who track this sort of thing. Feel free to join us, in any event. Remember, no prescription is required. Meanwhile, here are some tidbits. Have a lovely day and do stay in touch …

The California Senate voted in favor of a drug pricing transparency bill, which now goes to Gov. Jerry Brown. The bill has been vociferously fought by the pharmaceutical industry and could become one of the most comprehensive state efforts to address pricing transparency. Drug makers would have to provide 60-day notice to insurers and government health plans before increasing list prices of medicines by 16 percent in a two-year period.

Unlock this article by subscribing to STAT Plus and enjoy your first 30 days free!


What is it?

STAT Plus is a premium subscription that delivers daily market-moving biopharma coverage and in-depth science reporting from a team with decades of industry experience.

What's included?

  • Authoritative biopharma coverage and analysis, interviews with industry pioneers, policy analysis, and first looks at cutting edge laboratories and early stage research
  • Subscriber-only networking events and panel discussions across the country
  • Monthly subscriber-only live chats with our reporters and experts in the field
  • Discounted tickets to industry events and early-bird access to industry reports

Leave a Comment

Please enter your name.
Please enter a comment.

Sign up for our Daily Recap newsletter

A roundup of STAT’s top stories of the day in science and medicine

Privacy Policy